[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 1989

Is Minoxidil (Rogaine) Clinically Effective?

Author Affiliations

Department of Dermatology University of North Carolina Chapel Hill, NC 27514

Arch Dermatol. 1989;125(4):572. doi:10.1001/archderm.1989.01670160120037

To the Editor.—  At a recent live "educational" videoconference for dermatologists, it was announced that the makers of topical minoxidil (Rogaine) are soon to embark on a multimillion dollar advertising campaign direct to the public. While not mentioning minoxidil itself, this campaign would proclaim the availability of a medication approved for the treatment of male pattern baldness. The public would be directed to see a "physician or dermatologist" for more information. With the prospect of potentially millions of patients requesting more information, it is vital that we have a very clear understanding of the data demonstrating the effectiveness of this agent.The company's 12-page advertisement (appearing in every journal and "throw-away" crossing my desk in the past month) summarizes the results of the multicentered double-blind placebo-controlled studies: at 4 months, minoxidil was "significantly superior to placebo" by hair counts, and investigators' evaluation of hair growth demonstrated "a highly significant difference"

First Page Preview View Large
First page PDF preview
First page PDF preview